Patient Leaflet Updated 17-Apr-2026 | Aurobindo Pharma - Milpharm Ltd.
Alfuzosin HCl 2.5 mg film-coated tablets
Alfuzosin HCl 2.5 mg film-coated tablets
alfuzosin hydrochloride
1. What Alfuzosin HCl is and what it is used for
2. What you need to know before you use Alfuzosin HCl
3. How to use Alfuzosin HCl
4. Possible side effects
5. How to store Alfuzosin HCl
6. Contents of the pack and other information
Alfuzosin belongs to a group of medicines called alpha-blockers, medicines for problems with urination in the case of prostate disorders.
Use for:
Talk to your doctor or pharmacist or nurse before using Alfuzosin HCl
Note: the following comments can also apply to the use of medicines some time ago or in the near future.
The medicines mentioned in this section might be known to you by another name, often the trade name. In this section, only the name of the active substance or the category of active substances of the medicine is mentioned and not the trade name. For this reason, you should always take a good look at the packaging or the package insert to see what is the active substance of the medicine you are using.
Interaction means that medicines will have a bearing on each other’s effect and/or side effects when used together. Interaction can occur when these tablets are used with:
Tell your doctor or pharmacist if you are using, have recently taken or might take any other medicines.
As Alfuzosin HCl is not used in women, this section does not apply.
The use of Alfuzosin HCl can sometimes result in dizziness or general weakness (see “Possible side effects”). If you suffer from these side effects, do not drive any vehicle and/or operate any machinery which requires you to be alert.
This medicinal product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, that is to say essentially ‘sodium-free.’
Always use Alfuzosin HCl exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Alfuzosin HCl is not recommended for children.
The recommended dose is one 2.5 mg tablet three times a day. Your doctor may increase this to four times a day if needed.
In patients with poor kidney function:
The usual dose is two 2.5 mg tablets daily. Take the first tablet in the evening.
In patients with liver problems:
The usual dose is one 2.5 mg tablet daily. Your doctor may increase this to one 2.5 mg tablet twice a day (in the morning and evening).
Adults over 65, patients taking other medicines for high blood pressure, or patients with poor kidney function:
The initial dose is one 2.5 mg tablet twice a day (morning and evening).
If you are starting the treatment, it is best if you take the first tablet before you go to bed.
If you notice that Alfuzosin HCl has too strong or too weak an effect, consult your doctor or pharmacist.
Your doctor or pharmacist will tell you how long you should use Alfuzosin HCl. Alfuzosin HCl is prescribed for a fairly long period of time.
If you (or someone else) have taken too much Alfuzosin HCl, or you think a child has swallowed any of the tablets, contact your nearest hospital casualty department or your doctor immediately. If you have taken too much Alfuzosin HCl, you might suffer from low blood pressure. Lie down as much as possible, as this will help minimise the side effects.
If you forget to take a tablet, take one as soon as you remember, unless it is nearly time to take the next one. Do not take a double dose to make up for a forgotten tablet. Take your next dose at the usual time.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should see your doctor immediately if you experience the following symptoms:
Swollen face, tongue or throat; difficulty in swallowing; difficulty in breathing and hives (these symptoms occur in less than 1 in 10,000 persons treated).
The following side effects have been reported at the approximate frequencies shown:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Very rare (may affect up to 1 in 10, 000 people):
Additional side effects (Not known: frequency cannot be estimated from the available data) which may occur are:
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Alfuzosin HCl after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Film-coated tablet
White to off-white round, biconvex, film-coated tablets debossed with ‘X’ on one side and ‘31’ on other side.
Alfuzosin HCl is packed in PVC / PVdC-Aluminium foil blister packs or (HDPE) bottle packs.
Pack sizes:
Blister pack: 15, 30, 50, 60, 90 and 100 film-coated tablets
Bottle pack: 100, 250 and 1000 film-coated tablets
Not all pack sizes may be marketed.
or
This leaflet was last revised in 10/2025.
P1540043
Milpharm Limited, 1 Roundwood Avenue, Stockley Park, Uxbridge, UB11 1AF, UK
+ 44 (0)208 845 8811
+44 (0)208 845 8811
http://www.aurobindo.com
+44 (0)208 845 8795